A randomized phase II trial of 5-fluorouracil, with or without human interferon-β, for advanced colorectal cancer

por Villar-Grimalt, A, Candel, M T, Massuti, B, Lizón, J, Sánchez, B, Frau, A, Gorostidi, B, Goedkoop, R
Publicado 1999

Pegfilgrastim and daily granulocyte colony-stimulating factor: patterns of use and neutropenia-related outcomes in cancer patients in Spain – results of the LEARN Study

por ALMENAR, D, MAYANS, J, JUAN, O, BUENO, JM GARCIA, LOPEZ, JI JALON, FRAU, A, GUINOT, M, CEREZUELA, P, BUSCALLA, E GARCIA, GASQUET, JA, SANCHEZ, J
Publicado 2009

TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome

por Journe, F, Boufker, H Id, Van Kempen, L, Galibert, M-D, Wiedig, M, Salès, F, Theunis, A, Nonclercq, D, Frau, A, Laurent, G, Awada, A, Ghanem, G
Publicado 2011

Preventive treatments for breast cancer: recent developments

por Alés-Martínez, J. E., Ruiz, A., Chacón, J. I., Lluch Hernández, A., Ramos, M., Córdoba, O., Aguirre, E., Barnadas, A., Jara, C., González, S., Plazaola, A., Florián, J., Andrés, R., Sánchez Rovira, P., Frau, A.
Publicado 2014